PAIN THERAPEUTICS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Safety Study of PTI-125 in Healthy Volunteers

First Posted Date
2018-12-21
Last Posted Date
2021-05-10
Lead Sponsor
Pain Therapeutics
Target Recruit Count
24
Registration Number
NCT03784300
Locations
🇺🇸

Worldwide Clinical Trials, San Antonio, Texas, United States

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Phase 2
Completed
Conditions
Alzheimer Disease
Interventions
Drug: PTI-125, 100 mg tablets
First Posted Date
2018-11-21
Last Posted Date
2021-07-07
Lead Sponsor
Pain Therapeutics
Target Recruit Count
13
Registration Number
NCT03748706
Locations
🇺🇸

Insite Clinical Research, DeSoto, Texas, United States

🇺🇸

Clinical Trials of Texas, San Antonio, Texas, United States

Nasal Human Abuse Potential of PTI-821

First Posted Date
2018-03-23
Last Posted Date
2018-03-23
Lead Sponsor
Pain Therapeutics
Target Recruit Count
38
Registration Number
NCT03475862
Locations
🇺🇸

PRA-EDS, Salt Lake City, Utah, United States

Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycodone
Drug: Naltrexone
First Posted Date
2014-06-18
Last Posted Date
2016-04-04
Lead Sponsor
Pain Therapeutics
Target Recruit Count
17
Registration Number
NCT02165930
Locations
🇺🇸

Pfizer Investigational Site, Overland Park, Kansas, United States

Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycodone
First Posted Date
2014-04-21
Last Posted Date
2016-04-04
Lead Sponsor
Pain Therapeutics
Target Recruit Count
34
Registration Number
NCT02117583
Locations
🇺🇸

Pfizer Investigational Site, Overland Park, Kansas, United States

Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycodone
First Posted Date
2014-03-17
Last Posted Date
2016-04-04
Lead Sponsor
Pain Therapeutics
Target Recruit Count
18
Registration Number
NCT02089295
Locations
🇺🇸

Pfizer Investigational Site, Overland Park, Kansas, United States

Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycodone
First Posted Date
2014-02-11
Last Posted Date
2016-04-04
Lead Sponsor
Pain Therapeutics
Target Recruit Count
134
Registration Number
NCT02059915
Locations
🇺🇸

Pfizer Investigational Site, St. Paul, Minnesota, United States

Abuse Potential Study of PF-00345439

Phase 1
Completed
Conditions
Opioid Users
Interventions
Drug: PF-00345439
Drug: Capsule
Drug: oxycodone
First Posted Date
2013-11-18
Last Posted Date
2016-04-04
Lead Sponsor
Pain Therapeutics
Target Recruit Count
67
Registration Number
NCT01986283
Locations
🇺🇸

Lifetree Clinical Research, Salt Lake City, Utah, United States

Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycodone
First Posted Date
2013-08-16
Last Posted Date
2015-08-31
Lead Sponsor
Pain Therapeutics
Target Recruit Count
18
Registration Number
NCT01924676
Locations
🇺🇸

Pfizer Investigational Site, Baltimore, Maryland, United States

Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Oxycodone
First Posted Date
2012-10-30
Last Posted Date
2015-08-31
Lead Sponsor
Pain Therapeutics
Target Recruit Count
19
Registration Number
NCT01717027
Locations
🇺🇸

Pfizer Investigational Site, New Haven, Connecticut, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy